Monitoring of beta-Blockers Ozone Degradation via Electrospray Ionization Mass Spectrometry by Quispe, C. et al.
Article 
J. Braz. Chem. Soc., Vol. 22, No. 5, 919-928, 2011.
Printed in Brazil - ©2011  Sociedade Brasileira de Química
0103 - 5053  $6.00+0.00 A
*e-mail: lssantos@utalca.cl
Monitoring of b-Blockers Ozone Degradation via Electrospray Ionization Mass 
Spectrometry
Cristina Quispe,a,d Fabiane M. Nachtigall,b Maria Francesca R. Fonseca,b Rosana M. 
Alberici,b Luis Astudillo,c Jorge Villaseñor,a Marcos N. Eberlinb and Leonardo S. Santos*,d
aLaboratory of Physical Chemistry, Instituto de Química de Recursos Naturales, Talca University, 
PO Box 747, Talca, Chile
bThoMSon Mass Spectrometry Laboratory, Institute of Chemistry, University of Campinas, 
13083-970 Campinas-SP, Brazil
cLaboratory of Organic Synthesis and dLaboratory of Asymmetric Synthesis, 
Talca University, PO Box 747, Talca, Chile
As estruturas dos produtos de degradação mediada por ozônio de diferentes compostos 
farmacêuticos foram estudadas. Uma completa degradação do nadolol foi observada nas 
condições empregadas após 100 min. Os produtos de degradação obtidos nas soluções aquosas 
foram caracterizados por espectrometria de massas com ionização por electrospray (ESI-MS e 
ESI-MS/MS). O mecanismo proposto para a degradação consiste inicialmente do ataque de ozônio 
ao grupo amino da anilina formando nitro compostos, seguida de uma série de processos oxidativos. 
Monitoramento por ESI-MS(/MS) mostrou que a degradação de atenolol (ATE) e acebutolol (ACE) 
por ozônio ocorrem via um mecanismo similar ao do nadolol.
The structures of intermediate products of ozone degradation of different pharmaceutical 
compounds have been studied. Under the conditions employed, complete ozone degradation of 
nadolol was achieved after 100 min. The degradation products obtained in aqueous solution were 
characterized by electrospray ionization mass (and tandem mass) spectrometry (ESI-MS and 
ESI-MS/MS). The proposed mechanism for degradation, ozone attacks at the aniline amino group 
giving rise to nitro compounds and further degradation occurs via a series of oxidative processes. 
Continuous online monitoring by ESI-MS(/MS) with high accuracy mass measurements showed 
that ozone degradation of atenolol (ATE) and acebutolol (ACE) occurs via mechanisms similar 
to that of nadolol. 
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Introduction
Concerns about the prejudicial effects to life of 
accumulation of pharmaceuticals in the environment has 
greatly increased in recent years.1,2 But such accumulation 
is governed mainly by the environmental bio- and 
photo-transformation3 and the speed and nature of the natural 
degradation of these potentially harmful contaminants.4,5 
The photolytic degradation of chemicals in the environment 
may occur via direct sunlight absorption or by reactions 
with strong oxidizing species such as hydroxyl radicals 
and singlet oxygen. 
Pharmaceuticals enter the aquatic environment 
after its ingestion by humans and other animals and 
subsequent excretion, either in their intact forms or as 
metabolites.6 Wastewater treatment is applied worldwide 
but pharmaceuticals may not be efficiently removed,3,7 and 
these pharmaceutical residues and degradation products can 
be downloaded directly into aquatic environments. Several 
studies have stated that the long-term risk to humans from 
any single pharmaceutical at sub-mg L-1 levels is negligible, 
but the toxicological implications of chronic exposure to 
trace contaminants is still unclear.8,9
Ozonation is an advanced oxidation process widely used in 
many wastewater treatment plants for the oxidation of organic 
contaminants and disinfection. Ozone, compared to other most 
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common oxidizing reagents such as H2O2 or chlorine, is more 
efficient in pollutant degradation and less harmful to most 
living organisms.10 In water, ozone can oxidize contaminants 
via direct selective reactions11 such as ozone addition to 
double bonds or the initiation of chain radical reactions by the 
production of free hydroxy radicals (equations 1- 4). Hydroxy 
radicals are generated from ozone decomposition, which is 
catalyzed by the presence of hydroxyl anions or by traces of 
other substances, such as transition metal cations.
O3 + H2O → 2 HO· + O2  (1)
O3 + OH- → O2·– + HO2·  (2)
O3 + HO· → O2 + HO2·  (3)
O3 + HO2· → 2 O2 + HO·  (4)
The decomposition of ozone in aqueous solutions 
is known to proceed via the chain reactions shown in 
equations 1- 4.12 Ozone therefore indirectly attacks organic 
compounds since such reactions are faster than direct 
O3 attack. In previous studies,13,14 we described the O3 
interaction with pharmaceutical compound nadolol (anti-
hypertensive). In this study, we report the characterization 
via electrospray ionization mass spectrometry (ESI-MS)15,16 
of the oxidation intermediates and products of degradation 
of nadolol generated during O3 oxidation. Furthermore, the 
O3 degradation of two other b-blockers compounds atenolol 
and acebutolol was also studied. 
ESI-MS (and its tandem version ESI-MS/MS) has 
been used extensively to monitor the composition and 
degradation of organic compounds in the environment.17,18 
ESI-MS(/MS) with its unique characteristics has become a 
major technique to elucidate reaction mechanism especially 
in aqueous solutions via the detection and identification of 
reactants, products, and intermediates,19,20 even the short-
lived ones that occur at very low concentrations.21,22
Gas chromatography-mass spectrometry (GC-MS) has 
often been the technique of choice for reaction screening 
and product elucidation.23 However, GC-MS is an 
offline technique that demands extraction and sometimes 
derivatization pre-steps, transient, most polar, or relatively 
unstable compounds may be missed. We have then performed 
ESI-MS(/MS) monitoring of the O3 advanced oxidation of 
nadolol, atenolol and acebutolol in water to search for all 
intermediates and products of this environmentally important 
process. These products are the ones most likely to be found 
in treated wastewaters. We also used high performance liquid 
chromatography (HPLC), ultraviolet spectroscopy (UV), and 
total organic carbon (TOC) analyses to collect additional 
data on substrate degradation rates and mineralization and 
to investigate the presence of residual organic compounds 
in the aqueous solutions.24
Experimental
Chemicals
Nadolol (NAD), atenolol (ATE) and acebutolol (ACE) 
were purchased from Sigma. All the solvents were of 
HPLC grade and purchased from Merck and used without 
purification. Doubly distilled water was used to prepare 
all the solutions in the experiments. Ozone was generated 
using a laboratory ozone generation (OZOCAV) ozonizer 
fed with air/oxygen.
Degradation procedures
The ozonation reactions were performed in a batch glass 
reactor thermostated at 25 °C. The reactor was charged with 
100 mL of the drug aqueous solutions (1.6 × 10-4 mol L-1) 
and fed with 1.2 × 10-4 mol L-1 of ozone at a constant 
flow of 46 ± 1 mL min-1. The ozone concentration was 
monitored measuring the absorbance at 254 nm, using the 
molar extinction coefficient of ozone of 2900 L mol-1 cm-1. 
Aliquots (1.0 mL) were taken at several reaction times 
and promptly analyzed by ESI-MS(/MS) and HPLC. All 
samples were protected from light and refrigerated at 4 °C 
prior to analyses.
Analytic methods
Drugs concentrations were monitored using a Perkin 
Elmer Series 200 chromatograph HPLC system equipped 
with a UV-Vis detector. A Merck-Chromolith Performance 
RP-18 column (4.6 mm × 100 mm) was used with 
H2O:MeOH (70:30, v/v) mobile phase at a flow rate of 
0.6 mL min-1. Water was previously acidified to pH 3 using 
aqueous solution of HCl. Organic acids were quantified 
with a transgenomic ORH-801 column (6.5 mm × 300 mm) 
using 5.0 × 10-3 mol L-1 sulphuric acid as mobile phase at 
a flow rate of 0.8 mL min-1. 
Ultraviolet (UV) absorbance measurements were 
performed using a HP 8453 (Agilent) spectrophotometer 
equipped with a quartz cell with a 1.0 cm path length. 
Absorbances were measured with baseline correction, 
scan rate of 200-600 nm, and integrate time of 0.5 s and 
intervals of 1 nm.
Total organic carbon (TOC) experiments were carried 
out in a TOC 5000A (Shimadzu) instrument at 680 °C using 
a platinum catalyst.
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ESI-MS(/MS) data were collected using a high 
resolution hybrid quadrupole (Q) and orthogonal time-of-
flight (TOF) mass spectrometer (Q-Tof, Micromass UK) 
with constant nebulizer temperature of 50 °C. The ESI 
source and the mass spectrometer were operated in the 
positive ion mode, and the cone and extractor potentials 
were set to 40 and 10 V, respectively, with a scan range of 
m/z 50-1000. Samples were infused into the ESI source 
at flow rates of ca 15 mL min-1 via a microsyringe pump. 
ESI-MS/MS experiments were carried out by selection of a 
specific ion in Q1 and by performing its collision-induced 
dissociation (CID) with argon in the collision chamber. 
The product ions MS analysis was accomplished with the 
high-resolution (ca. 5.000) and high accuracy (ca. 10 ppm) 
orthogonal TOF analyzer. 
Results and Discussion
Degradation of nadolol
Our investigation began with HPLC monitoring for the 
O3 degradation of nadolol (NAD) in an aqueous solution at 
a concentration of 1.6 × 10-4 mol L-1 at pH 3 or 9, with O3 
concentration at 1.2 × 10-4 mol L-1 (Figure 1). Regardless 
the pH (acidic or basic), more than 90% of NAD was 
found to be degraded after 60 min at similar rates. TOC 
analyses were then performed to evaluate the mineralization 
extent, which was found to be only 20% according to TOC 
removal. This result suggests that NAD was completely 
consumed after 60 min of O3 degradation, but desirable 
mineralization to CO2, H2O and NH3 was far for completion. 
UV monitoring of O3 degradation (Figure 2) also indicated 
complete NAD consumption, but little information is 
provided of the nature of the degradation products. 
The UV spectra of Figure 2i show three characteristic 
absorption bands of nadolol at 203, 217 and 277 nm. After 
O3 treatment, the UV spectra show that intensities of these 
absorption bands were greatly reduced, suggesting nadolol 
was degraded, but not totally mineralized with persistent 
organic intermediates. 
Figure 1. HPLC monitoring of the ozonation of nadolol at pH 3 () and 
pH 9 ().
Figure 2. UV spectra of (i) an aqueous solution of nadolol at 
1.6 × 10-4 mol L-1, (ii) an aqueous solution of atenolol at 1.9 × 10-4 mol L-1, 
(iii) an aqueous solution of acebutolol at 1.5 × 10-4 mol L-1 and aliquots 
of the reaction mixture withdrawn after 60 min (iv) and 160 min (v) of 
ozone treatment respectively.
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ESI-MS(/MS) monitoring
Figure 3 displays representative ESI(+) mass spectra 
of nadolol aqueous solution (pH 9) monitored after 60, 
100 and 160 min from ozone treatment. Similar spectra 
(not shown) were acquired when using solutions at pH 3. 
The spectra at zero irradiation time (Figure 3a) detected, 
as expected, an intense ion of m/z 310 corresponding to 
protonated NAD. The ESI-MS/MS (Figure 4a) for collision 
induced dissociation of protonated NAD of m/z 310 shows 
a series of major and structurally diagnostic fragment ions 
arising from the loss of isobutene (m/z 254), H2O plus 
isobutene (m/z 236), 2 × H2O plus isobutene (m/z 218) and 
NH3 plus 2 × H2O and isobutene (m/z 201). 
The degradation process was monitored by intervals of 
20 min during 160 min of reaction. Illustrative spectra are 
displayed in Figure 3. The degradation of nadolol of m/z 310 
was clearly perceived as well as the formation of organic 
intermediates. After 60 min of ozonation (Figure 3b), three 
additional and increasingly abundant ions of m/z 92, 148 
and 236 were detected. The ion of m/z 148 (Figure 3d), 
which indicates the loss of a subunit of 161 Da (from 
nadolol of 309 Da), was characterized as the protonated 
form of dihydroxylamine 2 (Figure 5). Further degradation 
of 2 afforded hydroxylamine [3 + H]+ by loss of isobutene 
as noted through the ion of m/z 92, as depicted in Figure 3d.
The ion of m/z 236 (Figure 3d) was likely formed 
by aromatic ring opening, which produced a series of 
degradation products detected as the ions of m/z 378, 
342 and 376. Furthermore, ESI-MS was able to gently 
and efficiently fish directly from the solution to the gas 
phase for MS analysis also an increasingly abundant ion 
of m/z 236. This ion was characterized as aminotriol 9 
(Figure 5). Figure 4c shows the ESI-MS/MS spectra of 
intermediate [9 + H]+ that dissociated by loss of isobutene 
(C4H8) producing the fragment ion of m/z 180. That loss is 
indicative of tert-butyl group in the molecule, as observed 
in Figure 4. Another interesting fragmentation pathway was 
observed for [9 + H]+ by loss of C4H8O2, which structure 
could be realized as 2-hydroxytetrahydrofuran. 
Two major mechanisms can be considered for O3 
treatment. The first one assumes O3 addition to double 
bonds, whereas the second considers indirect reaction in 
water via hydroxyl radicals (equations 1-4). Formation 
of lower and higher masses intermediates was observed. 
Considering the lower mass compounds, Figure 5 presents 
a proposed route of degradation based on the ESI-MS(/MS) 
data, whereas Figure 6 presents proposed pathways 
Figure 3. ESI(+) Mass spectra acquired for aliquots of the reaction mixture after O3 treatment of nadolol at pH 9 for (a) 0 min; (b) 60 min; (c) 100 min 
and (d) 160 min.
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Figure 4. ESI-MS/MS of (a) protonated nadolol [1 + H]+ of m/z 310; (b) the ion of m/z 148 attributed to [2 + H]+; and (c) the ion of m/z 236 attributed to 
[9 + H]+.
leading to the higher mass products. HPLC analyses with 
standards corroborated unequivocally the structure of 
several structures proposed for the intermediates detected 
and characterized by ESI-MS(/MS). Among them are 
oxalic acid, formic acid and glyoxylic acid, which are 
known as recalcitrant compounds very resistant to further 
degradations.13 The resistance for this class of compounds is 
due to the lack of C–H bonds, and this may explaining why 
oxalic acid was less susceptible to OH• radicals attack which 
are produced mainly at high pH from O3. Thus, although 
the parent NAD was totally consumed by O3 treatment at 
different pH in a similar reaction rates, the intermediates 
observed in solution at pH 3 or 9 were different.
Degradation of atenolol
The degradation of atenolol (ATE) by O3 was monitored 
at either pH 3 or 9. Figure 2 shows UV spectra of the 
degradation of atenolol (1.9 ×10-4 mol L-1) by ozone at 
pH 3. Similar results (not shown) were obtained at pH 9. 
Three characteristic absorption bands of atenolol at seen 
at 200, 223 and 274 nm. TOC analyses indicated only 15% 
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Figure 5. Mechanism proposed for nadolol (NAD) degradation by ozone based on ESI-MS(/MS) data (lower mass products).
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Figure 6. Mechanism proposed for nadolol (NAD) degradation by ozone based on ESI-MS(/MS) data (higher mass products).
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of mineralization. These results suggested, as for NAD, 
that the mineralization leading to CO2, H2O and NH3 was 
mostly incomplete.
Figure 7 displays representative ESI(+)-MS of atenolol 
aqueous solutions according with time at pH 3. Similar 
spectra (not shown) were acquired at pH 9. The ESI-MS 
at zero irradiation time (Figure 7a) shows, as expected, 
predominantly the ion of m/z 267 for protonated ATE. 
After 160 min of ozonation (Figure 7b), ATE (m/z 267) was 
totally consumed and three intense ions of m/z 134, 206 
and 222 were observed. It was reported that photocatalytic 
TiO2 degradation25 and biological advanced oxidation26 
of atenolol afforded comparable degradation products as 
characterized by ESI-MS. Furthermore, the degradation 
species reported through TiO2 and biodegradation 
suggested a HO· radical Fenton-like pathway showing 
higher mass products than observed by us. However, based 
on the ESI-MS(/MS) data, a different mechanism for O3 
treatment of atenolol is proposed as depicted in Figure 8. 
Degradation of acebutolol 
Figure 2 shows the UV spectra for the O3 treatment 
of acebutolol (1.5 × 10-4 mol L-1). The two characteristic 
absorption bands of acebutolol are those at 231 and 320 nm. 
As observed previously for nadolol and atenolol, complete 
consumption of the parent molecule is achieved but 15% 
of TOC removal was observed.
Figure 9 displays two representative ESI(+)-MS of 
acebutolol solutions for O3 treatment. The ESI-MS at 
zero irradiation time (Figure 9a) detects, as expected, the 
ion of m/z 337 corresponding to protonated acebutolol. 
Figure 7. ESI(+) Mass spectra acquired for aliquots of the reaction mixture after degradation of atenolol with ozone system for (a) 0 min and (b) 160 min.
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Figure 9. ESI(+) Mass spectra acquired for aliquots of the reaction mixture after O3 degradation of acebutolol for (a) 0 min and (b) 160 min.
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After ozonation for 160 min (Figure 9b), acebutolol was 
completely consumed and four ions of m/z 134, 206, 222 
and 284 were observed. These ions were characterized 
by ESI-MS/MS experiments and based on the MS data 
Figure 10 proposes a mechanism for its O3 treatment, 
assuming similar degradation pathways as proposed 
previously for atenolol and nadolol. Table 1 summarizes the 
accurate mass data of product ions for all species identified 
during the degradation processes of NAD, ATE and ACE. 
Conclusions
As exempl i f i ed  here in  fo r  th ree  common 
pharmaceuticals, ESI mass spectrometry (and its tandem 
version) is a powerful technique able to provide detailed 
information about organic intermediates connecting 
parent molecules and final mineralization products 
during advanced oxidation processes. The ability to fish 
reactants, products, and intermediates (either ionic species 
or neutral species in their protonated or deprotonated 
forms) directly from the solution to the gas phase with 
gentleness, speed, and high sensitivity allows a detailed 
overview of the process and the interception and structural 
characterization of major players of the oxidation process. 
Whereas classical offline approaches such as GC-MS 
analysis can handle the more volatile and lighter species, 
the more polar, relatively unstable, or even transient 
intermediates or products, which may escape detection 
by other offline techniques or online techniques based 
on volatile species, may be intercepted and structurally 
characterized by online and real-time ESI-MS and 
ESI-MS/MS monitoring.
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